Browse diseases

…ferating B and T-cells, suggesting potential effector function. Melanoma-BM LAs also had increased intratumoral CD8+T-cells, unlike LUAD-BM…

…try, and was able to both directly recognize NY-ESO + HLA-DP04+ melanoma tumor cells as well as HLA-DP04+ monocyte-derived dendritic cel…

…ciates with an immune activated ‘hot’ tumor microenvironment.In melanoma, elevated baseline activated CD8+ central memory T cells and pr…

…ing of checkpoint of BRAF/MEK inhibitors on brain metastasis in Melanoma. NEJM Evid. 2024;3(10).Schürch, CM, et al. coordinated cellular…

…Background Unleashing the immune anti-tumor response against metastatic melanoma through immune checkpoint blockade (ICB) therapies have redefin…

… immune checkpoint inhibitors have shown success in a subset of melanoma patients, 1 their efficacy requires T cell infiltration and mig…

…-I-shared melanoma peptides (12MP) plus six class-II-restricted melanoma helper peptides (6MHP; cognate help) had improved long-term cli…

… (IL-1β and IL-6) responses. Notably, in melanoma (B16-F10) and glioblastoma (CT-2A) in vivo models, IBDV treatment delayed tumor growth and…

…Methods To investigate the T cell response directed against the melanoma antigen landscape, we performed a comprehensive analysis of tum…

…econdary objectives.Results The study enrolled 12 patients with melanoma (n=9), head and neck squamous cell carcinoma (HNSCC; n=1), rena…

…bsequently tumor immunity. In this study we used the transgenic melanoma mouse model tg(Grm1)EPv, which spontaneously develops melanoma …

… during dose-escalation (21%; n=19), and in the CPI-experienced melanoma (8%, n=38) and CPI-naïve ESCC (20%, n=15) expansion cohorts.Con…